Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Deficit (Unaudited)

v3.23.3
Condensed Consolidated Statements of Changes in Stockholders’ Deficit (Unaudited) - USD ($)
Special Voting Preferred Stock
Common
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 2,366,038 $ 155 $ 146,030,203 $ 61,523 $ (88,508,236) $ 59,949,683
Balance (in Shares) at Dec. 31, 2021 309,286 1,550,094        
Conversion of exchangeable shares to common stock $ (18,620) 18,620
Conversion of exchangeable shares to common stock (in Shares) (2,434) 122        
Settlement of convertible notes $ 17 3,299,983 3,300,000
Settlement of convertible notes (in Shares)   169,843        
Shares withheld for withholding taxes (5,615) (5,615)
Shares withheld for withholding taxes (in Shares)   (222)        
Shares returned in connection with acquisition $ (1) (939,999) (940,000)
Shares returned in connection with acquisition (in Shares)   (13,988)        
Stock-based compensation 316,855 316,855
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock upon vesting of restricted stock units (in Shares)   2,174        
Liabilities with shares 45,066 45,066
Liabilities with shares (in Shares)   732        
Foreign currency translation adjustments (33,800) (33,800)
Unrealized gain loss on convertible notes 101,000 101,000
Net loss (21,952,893) (21,952,893)
Balance at Mar. 31, 2022 $ 2,347,418 $ 171 148,765,113 128,723 (110,461,129) 40,780,296
Balance (in Shares) at Mar. 31, 2022 306,852 1,708,755        
Balance at Dec. 31, 2021 $ 2,366,038 $ 155 146,030,203 61,523 (88,508,236) 59,949,683
Balance (in Shares) at Dec. 31, 2021 309,286 1,550,094        
Net loss           (53,822,928)
Balance at Sep. 30, 2022 $ 2,227,619 $ 402 159,841,800 356,028 (142,331,164) 20,094,685
Balance (in Shares) at Sep. 30, 2022 291,192 4,023,294        
Balance at Mar. 31, 2022 $ 2,347,418 $ 171 148,765,113 128,723 (110,461,129) 40,780,296
Balance (in Shares) at Mar. 31, 2022 306,852 1,708,755        
Conversion of exchangeable shares to common stock $ (119,799) 119,799
Conversion of exchangeable shares to common stock (in Shares) (15,660) 783        
Shares returned in connection with the ATM offering program $ 9 761,169 761,178
Shares returned in connection with the ATM offering program (in Shares)   90,809        
Settlement of convertible notes $ 4 625,496 625,500
Settlement of convertible notes (in Shares)   37,584        
Shares withheld for withholding taxes (7,552) (7,552)
Shares withheld for withholding taxes (in Shares)   (337)        
Stock-based compensation 148,444 148,444
Issuance of common stock upon vesting of restricted stock units 25,000 25,000
Issuance of common stock upon vesting of restricted stock units (in Shares)   3,011        
Liabilities with shares 4,464 4,464
Liabilities with shares (in Shares)   732        
Foreign currency translation adjustments 10,629 10,629
Unrealized gain loss on convertible notes 163,000 163,000
Net loss (29,565,947) (29,565,947)
Balance at Jun. 30, 2022 $ 2,227,619 $ 184 150,441,933 302,352 (140,027,076) 12,945,012
Balance (in Shares) at Jun. 30, 2022 291,192 1,841,337        
Common shares and warrants issued in connection with unit offering $ 217 9,178,744 9,178,961
Common shares and warrants issued in connection with unit offering (in Shares)   217,913        
Stock-based compensation 196,124 196,124
Issuance of common stock upon vesting of restricted stock units $ 1 24,999 25,000
Issuance of common stock upon vesting of restricted stock units (in Shares)   8,045        
Foreign currency translation adjustments 27,676 27,676
Unrealized gain loss on convertible notes 26,000 26,000
Net loss (2,304,088) (2,304,088)
Balance at Sep. 30, 2022 $ 2,227,619 $ 402 159,841,800 356,028 (142,331,164) 20,094,685
Balance (in Shares) at Sep. 30, 2022 291,192 4,023,294        
Balance at Dec. 31, 2022 $ 2,185,391 $ 460 160,207,367 347,100 (167,565,846) (4,825,528)
Balance (in Shares) at Dec. 31, 2022 285,672 4,602,780        
Conversion of exchangeable shares to common stock $ (4,896) 4,896
Conversion of exchangeable shares to common stock (in Shares) (640) 32        
Settlement of convertible notes $ 116 1,396,985 1,397,101
Settlement of convertible notes (in Shares)   1,164,251        
Stock-based compensation 109,133 109,133
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock upon vesting of restricted stock units (in Shares)   587        
Foreign currency translation adjustments 20,429 20,429
Unrealized gain loss on convertible notes (14,000) (14,000)
Net loss (2,474,628) (2,474,628)
Balance at Mar. 31, 2023 $ 2,180,495 $ 576 161,718,381 353,529 (170,040,474) (5,787,493)
Balance (in Shares) at Mar. 31, 2023 285,032 5,767,650        
Balance at Dec. 31, 2022 $ 2,185,391 $ 460 160,207,367 347,100 (167,565,846) (4,825,528)
Balance (in Shares) at Dec. 31, 2022 285,672 4,602,780        
Net loss           (8,151,516)
Balance at Sep. 30, 2023 $ 1,907,941 $ 1,000 164,314,084 295,274 (175,717,363) (9,199,064)
Balance (in Shares) at Sep. 30, 2023 249,504 10,002,018        
Balance at Mar. 31, 2023 $ 2,180,495 $ 576 161,718,381 353,529 (170,040,474) (5,787,493)
Balance (in Shares) at Mar. 31, 2023 285,032 5,767,650        
Conversion of exchangeable shares to common stock $ (250,981) $ 1 250,980
Conversion of exchangeable shares to common stock (in Shares) (32,808) 1,640        
Shares issued in a private placement offering $ 100 499,900 500,000
Shares issued in a private placement offering (in Shares)   1,000,000        
Settlement of convertible notes $ 23 114,977 115,000
Settlement of convertible notes (in Shares)   230,000        
Stock-based compensation 108,477 108,477
Foreign currency translation adjustments 8,574 8,574
Unrealized gain loss on convertible notes (25,000) (25,000)
Net loss (3,081,951) (3,081,951)
Balance at Jun. 30, 2023 $ 1,929,514 $ 700 162,692,715 337,103 (173,122,425) (8,162,393)
Balance (in Shares) at Jun. 30, 2023 252,224 6,999,290        
Conversion of exchangeable shares to common stock $ (2,157) 21,573
Conversion of exchangeable shares to common stock (in Shares) (2,720) 141        
Settlement of convertible notes $ 300 1,499,700 1,500,000
Settlement of convertible notes (in Shares)   3,000,000        
Stock-based compensation 100,096 100,096
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock upon vesting of restricted stock units (in Shares)   2,587        
Foreign currency translation adjustments (38,829) (38,829)
Unrealized gain loss on convertible notes (3,000) (3,000)
Net loss (2,594,938) (2,594,938)
Balance at Sep. 30, 2023 $ 1,907,941 $ 1,000 $ 164,314,084 $ 295,274 $ (175,717,363) $ (9,199,064)
Balance (in Shares) at Sep. 30, 2023 249,504 10,002,018